Conduit Pharmaceuticals Inc (NASDAQ: CDT) started the day on Thursday, with a price decrease of -7.61% at $0.07, before settling in for the price of $0.07 at the close. Taking a more long-term approach, CDT posted a 52-week range of $0.07-$6.73.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
It was noted that the giant of the Healthcare sector posted annual sales growth of 0.00% over the last 5 years. This publicly-traded company’s shares outstanding now amounts to $96.00 million, simultaneously with a float of $73.18 million. The organization now has a market capitalization sitting at $7.86 million. At the time of writing, stock’s 50-day Moving Average stood at $0.0984, while the 200-day Moving Average is $1.2323.
Conduit Pharmaceuticals Inc (CDT) Ownership Facts and Figures
Now let’s turn our focus to how large-scale investors are working with this stock of the Biotechnology Industry. Conduit Pharmaceuticals Inc’s current insider ownership accounts for 38.95%, in contrast to 3.38% institutional ownership. According to the most recent insider trade that took place on Oct 03 ’24, this organization’s 10% Owner sold 1,500,000 shares at the rate of 0.10, making the entire transaction reach 156,450 in total value, affecting insider ownership by 8,400,000. Preceding that transaction, on Oct 04 ’24, Company’s 10% Owner sold 1,368,991 for 0.10, making the whole transaction’s value amount to 140,458. This particular insider is now the holder of 7,031,009 in total.
Conduit Pharmaceuticals Inc (CDT) Earnings and Revenue Records
Wall Street market experts anticipate that the next fiscal year will bring earnings of 0 per share during the current fiscal year.
Conduit Pharmaceuticals Inc (NASDAQ: CDT) Trading Performance Indicators
Let’s observe the current performance indicators for Conduit Pharmaceuticals Inc (CDT). It’s Quick Ratio in the last reported quarter now stands at 0.12. The Stock has managed to achieve an average true range (ATR) of 0.01.
In the same vein, CDT’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -0.21.
Technical Analysis of Conduit Pharmaceuticals Inc (CDT)
If we take a close look at the recent performances of Conduit Pharmaceuticals Inc (NASDAQ: CDT), its last 5-days Average volume was 14.71 million that shows progress from its year to date volume of 10.0 million. During the previous 9 days, stock’s Stochastic %D was recorded 7.37% While, its Average True Range was 0.0117.
Raw Stochastic average of Conduit Pharmaceuticals Inc (CDT) in the period of the previous 100 days is set at 0.37%, which indicates a major fall in contrast to 2.38% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 75.28% that was lower than 112.58% volatility it exhibited in the past 100-days period.
